News - Page 2 of 3 - Selux Diagnostics

In the News

BARDA grants additional funding for rapid antibiotic susceptibility test

June 14, 2021

Selux awarded $14.6 million from BARDA for rapid antimicrobial susceptibility testing

June 14, 2021

Selux Diagnostics receives additional $14.6M in BARDA funding after successfully completing first clinical trial

June 14, 2021

Selux Diagnostics Receives Additional $14.6 Million in BARDA Funding After Successfully Completing First Clinical Trial

June 9, 2021

Selux Diagnostics Nabs Additional $9.6M BARDA Payment for AST Technology

April 27, 2020

Selux Diagnostics Receives $9.6M For Development of Rapid Antimicrobial Testing

April 27, 2020

Selux Diagnostics Receives $9.6 Million in Additional Funding, Speeding Development of Breakthrough Rapid AST Platform

April 27, 2020

New Genomic Tests Aim to Diagnose Deadly Infections Faster

February 24, 2020

ECCMID 2020 Alert: Selux Diagnostics Hosting Integrated Symposium at 30th European Congress of Clinical Microbiology & Infectious Diseases

February 18, 2020

Diagnostics Startups Take On Growing Threat of Antibiotic-Resistant Bugs

January 14, 2020

New Diagnostic Tools are Essential in the Battle Against Antibiotic Resistance

October 24, 2019

Selux Leverages Government Support to Develop Rapid Antibiotic Susceptibility Test

October 9, 2019

Selux Diagnostics Receives $11.4M Milestone Payment Under BARDA Contract

October 2, 2019

Selux Diagnostics Beats Key Contract Milestone, Receives $11.4M in Additional Funding

October 2, 2019

Selux Diagnostics Selected to lead IDWeek 2019 Panel Presentation, Poster Session

September 10, 2019